Genmab A/S (GMAB)
30.06
-0.54
(-1.78%)
USD |
NASDAQ |
Feb 11, 16:00
30.06
0.00 (0.00%)
After-Hours: 20:00
Genmab Price : 30.06 for Feb. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 220.85 |
| Krystal Biotech, Inc. | 272.32 |
| Novo Nordisk A/S | 48.73 |
| Ascendis Pharma A/S | 221.19 |
| Zealand Pharma A/S | 63.84 |
Price Related Metrics
| PE Ratio | 12.76 |
| PS Ratio | 5.261 |
| PEG Ratio | 0.1007 |
| Price to Book Value | 3.214 |
| Price to Free Cash Flow | 15.55 |
| Earnings Yield | 7.84% |
| Market Cap | 18.48B |
| PEGY Ratio | 0.1007 |
| Operating PE Ratio | 14.28 |
| Normalized PE Ratio | 12.70 |